1.   

On 4 October 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

—	Sivantos Pte. Ltd. (‘Sivantos’, Singapore), controlled by EQT VI Limited and EQT Fund Management SARL (together referred to as ‘EQT’),

—	Widex A/S (‘Widex’, Denmark), controlled by Widex Holding A/S (‘Widex Holding’),

—	MergeCo A/S, a newly created entity (‘JV’, Denmark).

Widex Holding and EQT acquire, within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation, joint control over the JV, combining the activities of Widex and Sivantos.

The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2.   

The business activities of the undertakings concerned are:

—   Sivantos: global manufacturer and supplier of hearing aids and hearing accessories,

—   Widex: global manufacturer and supplier of hearing aids and hearing accessories,

—   the JV: global manufacturer and supplier of hearing aids and hearing accessories.

3.   

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.   

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.8941 — EQT/Widex/JV

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË